Status:
COMPLETED
Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma
Lead Sponsor:
The Catholic University of Korea
Conditions:
Huerthle Cell Carcinoma
Eligibility:
All Genders
Brief Summary
The goal of this retrospective study is to evaluate in patients with HCC and FTC who underwent lobectomy. The main questions it aims to answer are: * The necessity of completion thyroidectomy based o...
Detailed Description
Background The prognosis of Hürthle cell carcinoma (HCC) and follicular thyroid carcinoma (FTC) is poorly understood. These types of cancers are usually confirmed after diagnostic lobectomy. We aimed ...
Eligibility Criteria
Inclusion
- Follicular thyroid carcinoma
- Hurthle cell carcinoma
- Lobectomy
Exclusion
- Completion thyroidectomy
- Total thyroidectomy
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
221 Patients enrolled
Trial Details
Trial ID
NCT05968196
Start Date
January 1 2000
End Date
March 31 2023
Last Update
August 1 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.